miércoles, 18 de noviembre de 2015

Drug Information Update - New FDA Drug Info Rounds Video on Antibiotic Resistance

FDA Division of Drug Information: Know the Moment It Happens
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

FDA Drug Info Rounds is a series of training videos for practicing clinical and community pharmacists. Drug Info Rounds is brought to you by pharmacists in the FDA's Center for Drug Evaluation and Research (CDER), Office of Communications (OCOMM), Division of Drug Information (DDI). Pharmacists in DDI answer hundreds of questions everyday about drug products and FDA actions. Our goal is to provide important and timely drug information to pharmacists so they can help patients make better medication decisions.
In this video, the FDA Drug Info Rounds pharmacists discuss antibiotic resistance. Antibiotic resistance is a growing public health concern worldwide. FDA Drug Info Rounds pharmacists discuss how the nation’s pharmacists can encourage the appropriate use of antibiotics.
To watch the video, please visit: Antibiotic Resistance
Other videos coming soon in the new series of Drug Info Rounds include:
  • Breakthrough Therapy
  • MedWatch Tips & Tools (tutorial)
 The most popular videos from previous seasons include:
  • Accelerated Approval
  • Medication Errors
  • Disposal of Unused Medicines
  • Electronic Orange Book
Watch online at: http://go.usa.gov/ccfuh
Drug Info Rounds are created and produced by pharmacists in FDA’s Center for Drug Evaluation and Research, Office of Communications, Division of Drug Information (DDI).  DDI pharmacists respond to over 70,000 inquiries per year about FDA initiatives and regulated drugs from healthcare professionals, industry, and consumers.  The Drug Info Rounds video series provides important and useful drug information to health care providers helping them be better clinicians and, ultimately, improving patient safety.

This is an automated message delivery system.  Replying to this message will not reach DDI staff.  If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm ET Monday - Friday.  You can also email us at druginfo@fda.hhs.gov.

No hay comentarios:

Publicar un comentario